The ehrlich tumor induces pain-like behavior in mice: A novel model of cancer pain for pathophysiological studies and pharmacological screening

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Calixto Campos, Cassia ^a   Zarpelon, Ana C ^a   Corrêa, Mab ^a   Cardoso, Renato D R ^a   Pinho Ribeiro, Felipe A ^a   Cecchini, Rubens ^a   Moreira, Estefania G ^a   Crespigio, Jefferson ^a   Bernardy, Catia C F ^a   Casagrande, Rubia ^a   Verri Jr , Waldiceu A ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; INDOMETACIN; MORPHINE; NALOXONE;

ANALGESIC ACTIVITY; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER PAIN; CARTILAGE DEGENERATION; CELL DIFFERENTIATION; COMPARATIVE STUDY; CONTROLLED STUDY; EHRLICH ASCITES TUMOR; ERYTHROCYTE; HOT PLATE TEST; HYPERALGESIA; IMMUNE RESPONSE; MALE; MITOSIS; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PAW EDEMA; TUMOR CELL; TUMOR GROWTH; ANIMAL; CANCER TRANSPLANTATION; CELL PROLIFERATION; DISEASE MODEL; DRUG EFFECT; DRUG SCREENING; EDEMA; NOCICEPTION; PAIN; PATHOLOGY; SUBCUTANEOUS TISSUE; TEMPERATURE; CARCINOMA, EHRLICH TUMOR; COMPLICATION; DRUG EFFECTS;

AMITRIPTYLINE; ANIMALS; BEHAVIOR, ANIMAL; CARCINOMA, EHRLICH TUMOR; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; EDEMA; HYPERALGESIA; INDOMETHACIN; MALE; MICE; MORPHINE; NEOPLASM TRANSPLANTATION; NOCICEPTION; PAIN; SUBCUTANEOUS TISSUE; TEMPERATURE;

EID: 84884256628     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/624815     Document Type: Article

References (41)

1. Greenberg P. E., Leong S. A., Birnbaum H. G., Robinson R. L., The economic burden of depression with painful symptoms. Journal of Clinical Psychiatry 2003 64 7 17 23 2-s2.0-0037566541
2. Green C. R., Ndao-Brumblay S. K., Hart-Johnson T., Sleep problems in a racially diverse chronic pain population. Clinical Journal of Pain 2009 25 5 423 430 2-s2.0-67649513244 10.1097/AJP.0b013e3181a087aa
3. Stewart W. F., Ricci J. A., Chee E., Morganstein D., Lipton R., Lost productive time and cost due to common pain conditions in the US workforce. Journal of the American Medical Association 2003 290 18 2443 2454 2-s2.0-0242410368 10.1001/jama.290.18.2443
4. Turk D. C., Clinical effectiveness and cost-effectiveness of treatments for patients with chronic pain. Clinical Journal of Pain 2002 18 6 355 365 2-s2.0-0036844652 10.1097/00002508-200211000-00003
5. Anderson K. O., Mendoza T. R., Valero V., Richman S. P., Russell C., Hurley J., DeLeon C., Washington P., Palos G., Payne R., Cleeland C. S., Minority cancer patients and their providers: pain management attitudes and practice. Cancer 2000 88 8 1929 1938
6. Nelson J. E., Meier D. E., Oei E. J., Nierman D. M., Senzel R. S., Manfredi P. L., Davis S. M., Morrison R. S., Self-reported symptom experience of critically ill cancer patients receiving intensive care. Critical Care Medicine 2001 29 2 277 282 2-s2.0-0035113367
7. Caraceni A., Evaluation and assessment of cancer pain and cancer pain treatment. Acta Anaesthesiologica Scandinavica 2001 45 9 1067 1075 2-s2.0-0034781915 10.1034/j.1399-6576.2001.450903.x
8. Green C. R., Hart-Johnson T., Loeffler D. R., Cancer-related chronic pain. Cancer 2011 117 9 1994 2003 2-s2.0-79955427443 10.1002/cncr.25761
9. van den Beuken-van Everdingen M. H. J., de Rijke J. M., Kessels A. G., Schouten H. C., van Kleef M., Patijn J., Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Annals of Oncology 2007 18 9 1437 1449 2-s2.0-34548405245 10.1093/annonc/mdm056
10. Sasamura T., Nakamura S., Iida Y., Fujii H., Murata J., Saiki I., Nojima H., Kuraishi Y., Morphine analgesia suppresses tumor growth and metastasis in a mouse model of cancer pain produced by orthotopic tumor inoculation. European Journal of Pharmacology 2002 441 3 185 191 2-s2.0-0037177363 10.1016/S0014-2999(02)01450-4
11. Shimoyama M., Tanaka K., Hasue F., Shimoyama N., A mouse model of neuropathic cancer pain. Pain 2002 99 1-2 167 174 2-s2.0-0036711508 10.1016/S0304-3959(02)00073-8
12. Schwei M. J., Honore P., Rogers S. D., Salak-Johnson J. L., Finke M. P., Ramnaraine M. L., Clohisy D. R., Mantyh P. W., Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. Journal of Neuroscience 1999 19 24 10886 10897 2-s2.0-0033573528
13. Wacnik P. W., Eikmeier L. J., Ruggles T. R., Ramnaraine M. L., Walcheck B. K., Beitz A. J., Wilcox G. L., Functional interactions between tumor and peripheral nerve: morphology, algogen identification, and behavioral characterization of a new murine model of cancer pain. Journal of Neuroscience 2001 21 23 9355 9366 2-s2.0-0035576403
14. Mantyh P. W., Paice A. J., Bell R. F., Kalso E. A., Soyannwo O. A., Mechanisms of malignant bone pain. Cancer Pain: From Molecules to Suffering 2010 1st chapter 3 Washington, DC, USA IASP Press 45 62
15. Kress M., Paice A. J., Bell R. F., Kalso E. A., Soyannwo O. A., Cytokines and cancer pain. Cancer Pain: From Molecules to Suffering 2010 1st chapter 4 Washington, DC, USA IASP Press 63 84
16. Ehrlich P., Apolant H., Beobachtungen uber maligne mausetumoren. Berliner Klinische Wochenschrift 1905 42 871 874
17. Loewenthal H., Jahn G., Übertragunsversuche mit carcinomatöser Mäuse-Ascitesflüssigkeit und ihr Verhalten gegen physikalische und chemische Einwirkungen. Zeitschrift für Krebsforschung 1932 37 1 439 447 2-s2.0-0343170176 10.1007/BF01618550
18. Ahmed H., Chatterjee B. P., Debnath A. K., Interaction and in vivo growth inhibition of Ehrlich ascites tumor cells by jacalin. Journal of Biosciences 1988 13 4 419 424 2-s2.0-0024216478
19. Kametani S., Oikawa T., Kojima-Yuasa A., Kennedy D. O., Norikura T., Honzawa M., Matsui-Yuasa I., Mechanism of growth inhibitory effect of cape aloe extract in Ehrlich ascites tumor cells. Journal of Nutritional Science and Vitaminology 2007 53 6 540 546 2-s2.0-38549095476 10.3177/jnsv.53.540
20. Balamurugan E., Reddy B. V., Menon V. P., Antitumor and antioxidant role of Chrysaora quinquecirrha (sea nettle) nematocyst venom peptide against ehrlich ascites carcinoma in Swiss Albino mice. Molecular and Cellular Biochemistry 2009 338 1-2 69 76 2-s2.0-77951294676 10.1007/s11010-009-0339-3
21. Kumar A., D'Souza S. S., Mysore Nagaraj S. R., Gaonkar S. L., Salimath B. P., Rai K. M. L., Antiangiogenic and antiproliferative effects of substituted-1,3,4-oxadiazole derivatives is mediated by down regulation of VEGF and inhibition of translocation of HIF-1 α in Ehrlich ascites tumor cells. Cancer Chemotherapy and Pharmacology 2009 64 6 1221 1233 2-s2.0-69049091854 10.1007/s00280-009-0992-y
22. Fastaia J., Dumont A. E., Pathogenesis of ascites in mice with peritoneal carcinomatosis. Journal of the National Cancer Institute 1976 56 3 547 550 2-s2.0-0017258038
23. Hartveit F., The immediate cause of death in mice with Ehrlich's ascites carcinoma. Acta Pathologica et Microbiologica Scandinavica 1965 65 3 359 365 2-s2.0-0013835819
24. Mayer K. D., The pathogenicity of the Ehrlich ascites tumour. British Journal of Experimental Pathology 1966 47 5 537 544 2-s2.0-0013961881
25. Vieira J., Matsuzaki P., Nagamine M. K., Haraguchi M., Akisue G., Gorniak S. L., Dagli M. L. Z., Inhibition of ascitic Ehrlich tumor cell growth by intraperitoneal injection of Pfaffia paniculata (Brazilian ginseng) butanolic residue. Brazilian Archives of Biology and Technology 2010 53 3 609 613 2-s2.0-77955523176 10.1590/S1516-89132010000300014
26. Zhu X., Wu H., Xia J., Zhao M., Xianyu Z., The relationship between T 99 m c-MIBI uptakes and tumor cell death/proliferation state under irradiation. Cancer Letters 2002 182 2 217 222 2-s2.0-0037190122 10.1016/S0304-3835(02)00079- 4
27. Brigatte P., Sampaio S. C., Gutierrez V. P., Guerra J. L., Sinhorini I. L., Curi R., Cury Y., Walker 256 tumor-bearing rats as a model to study cancer pain. Journal of Pain 2007 8 5 412 421 2-s2.0-34247604907 10.1016/j.jpain.2006. 11.006
28. Cunha T. M., Verri W. A. Jr., Vivancos G. G., Moreira I. F., Reis S., Parada C. A., Cunha F. Q., Ferreira S. H., An electronic pressure-meter nociception paw test for mice. Brazilian Journal of Medical and Biological Research 2004 37 3 401 407 2-s2.0-1842450784
29. Valério D. A. R., Cunha T. M., Arakawa N. S., Lemos H. P., Da Costa F. B., Parada C. A., Ferreira S. H., Cunha F. Q., Verri W. A. Jr., Anti-inflammatory and analgesic effects of the sesquiterpene lactone budlein A in mice: inhibition of cytokine production-dependent mechanism. European Journal of Pharmacology 2007 562 1-2 155 163 2-s2.0-33947544247 10.1016/j.ejphar.2007. 01.029
30. Medhurst S. J., Walker K., Bowes M., Kidd B. L., Glatt M., Muller M., Hattenberger M., Vaxelaire J., O'Reilly T., Wotherspoon G., Winter J., Green J., Urban L., A rat model of bone cancer pain. Pain 2002 96 1-2 129 140 2-s2.0-0036212603 10.1016/S0304-3959(01)00437-7
31. Clohisy D. R., Ogilvie C. M., Ramnaraine M. L. R., Tumor osteolysis in osteopetrotic mice. Journal of Orthopaedic Research 1995 13 6 892 897 2-s2.0-0029410949 10.1002/jor.1100130613
32. Menendéz L., Juárez L., García V., Hidalgo A., Baamond A., Involvement of nitric oxide in the inhibition of bone cancer-induced hyperalgesia thought the activation of peripheral opioid receptors in mice. Neuropharmacology 2007 53 1 71 80
33. Kuraishi Y., Iida Y., Zhang H., Uehara S., Nojima H., Murata J., Saiki I., Takahata H., Ouchi H., Suppression by gabapentin of pain-related mechano-responses in mice given orthotopic tumor inoculation. Biological and Pharmaceutical Bulletin 2003 26 4 550 552 2-s2.0-0642347794
34. Luger N. M., Honore P., Sabino M. A. C., Schwei M. J., Rogers S. D., Mach D. B., Clohisy D. R., Mantyh P. W., Osteoprotegerin diminishes advanced bone cancer pain. Cancer Research 2001 61 10 4038 4047 2-s2.0-0035872471
35. Portenoy R. K., Frager G., Pain management: pharmacological approaches. Cancer Treatment and Research 1999 100 1 29 2-s2.0-0033286363
36. Shimoyama M., Tatsuoka H., Ohtori S., Tanaka K., Shimoyama N., Change of dorsal horn neurochemistry in a mouse model of neuropathic cancer pain. Pain 2005 114 1-2 221 230 2-s2.0-14044268646 10.1016/j.pain.2004.12.018
37. Mouedden M. E., Meert T. F., Pharmacological evaluation of opioid and non-opioid analgesics in a murine bone cancer model of pain. Pharmacology Biochemistry and Behavior 2007 86 3 458 467 2-s2.0-33947509987 10.1016/j.pbb.2007.01.003
38. Saito O., Aoe T., Yamamoto T., Analgesic effects of nonsteroidal antiinflammatory drugs, acetaminophen, and morphine in a mouse model of bone cancer pain. Journal of Anesthesia 2005 19 3 218 224 2-s2.0-23144446942 10.1007/s00540-005-0323-3
39. Vissers K., Hoffmann V., Geenen F., Biermans R., Meert T., Is the second phase of the formalin test useful to predict activity in chronic constriction injury models? A pharmacological comparison in different species. Journal of World Institute of Pain 2003 3 4 298 309
40. Harris W. G., Benson E. A., Cartwright D., Cartwright S. C., Clayden A. D., Cowen P. N., Dosset J. A., Edwards M., Frank H. G., Gowland G., Hall R., Hopton D. S., Joslin C. A. F., Logan V. S. D., Mackinnon D., McAdam W. A. F., McCracken M., Matheson T. S., Modgill V. K., Price J. J., Smiddy F. G., Whittaker M., Wilkinson A., Wilson G., Wilson K., Symptoms and signs of operable breast cancer. The Journal of the Royal College of General Practitioners 1983 33 473 476
41. Kroner K., Krebs B., Skov J., Jorgensen H. S., Immediate and long-term phantom breast syndrome after mastectomy: incidence, clinical characteristics and relationship to pre-mastectomy breast pain. Pain 1989 36 3 327 334 2-s2.0-0024503876